{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:29:56Z","timestamp":1791563396622,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["113TMU-SHH-02"],"award-info":[{"award-number":["113TMU-SHH-02"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01538-4","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:34:38Z","timestamp":1738355678000},"page":"4711-4732","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer"],"prefix":"10.1007","volume":"47","author":[{"given":"Chia-Chang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yi","family":"Tzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-3744","authenticated-orcid":false,"given":"Chien Hsiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"issue":"1","key":"1538_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1538_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1538_CR3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/00000658-194206000-00030","volume":"115","author":"C Huggins","year":"1942","unstructured":"Huggins C. Effect of orchiectomy and irradiation on cancer of the prostate. Ann Surg. 1942;115(6):1192\u2013200.","journal-title":"Ann Surg"},{"issue":"11","key":"1538_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrd4068","volume":"12","author":"D Trewartha","year":"2013","unstructured":"Trewartha D, Carter K. Advances in prostate cancer treatment. Nat Rev Drug Discov. 2013;12(11):823\u20134.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"1538_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","volume":"18","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Molecular events in neuroendocrine prostate cancer development. Nat Rev Urol. 2021;18(10):581\u201396.","journal-title":"Nat Rev Urol"},{"issue":"19","key":"1538_CR6","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1074\/jbc.M114.547448","volume":"289","author":"V Porcelli","year":"2014","unstructured":"Porcelli V, et al. The human gene SLC25A29, of solute carrier family 25, encodes a mitochondrial transporter of basic amino acids. J Biol Chem. 2014;289(19):13374\u201384.","journal-title":"J Biol Chem"},{"issue":"40","key":"1538_CR7","doi-asserted-by":"publisher","first-page":"38796","DOI":"10.1074\/jbc.M306372200","volume":"278","author":"E Sekoguchi","year":"2003","unstructured":"Sekoguchi E, et al. A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting. J Biol Chem. 2003;278(40):38796\u2013802.","journal-title":"J Biol Chem"},{"issue":"1","key":"1538_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1203\/PDR.0b013e3181a283c1","volume":"66","author":"JA Camacho","year":"2009","unstructured":"Camacho JA, Rioseco-Camacho N. The human and mouse SLC25A29 mitochondrial transporters rescue the deficient ornithine metabolism in fibroblasts of patients with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Pediatr Res. 2009;66(1):35\u201341.","journal-title":"Pediatr Res"},{"issue":"3","key":"1538_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jgg.2020.02.007","volume":"47","author":"R Tang","year":"2020","unstructured":"Tang R, et al. Defective arginine metabolism impairs mitochondrial homeostasis in Caenorhabditiselegans. J Genet Genomics. 2020;47(3):145\u201356.","journal-title":"J Genet Genomics"},{"issue":"2","key":"1538_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1083\/jcb.201807204","volume":"218","author":"J Zhou","year":"2019","unstructured":"Zhou J, et al. The lysine catabolite saccharopine impairs development by disrupting mitochondrial homeostasis. J Cell Biol. 2019;218(2):580\u201397.","journal-title":"J Cell Biol"},{"issue":"19","key":"1538_CR11","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/s41388-018-0139-x","volume":"37","author":"H Zhang","year":"2018","unstructured":"Zhang H, et al. Elevated mitochondrial SLC25A29 in cancer modulates metabolic status by increasing mitochondria-derived nitric oxide. Oncogene. 2018;37(19):2545\u201358.","journal-title":"Oncogene"},{"issue":"1","key":"1538_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12935-023-03082-7","volume":"23","author":"P Zheng","year":"2023","unstructured":"Zheng P, et al. Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma. Cancer Cell Int. 2023;23(1):222.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1538_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12967-022-03756-2","volume":"20","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. An extensive bioinformatics study on the role of mitochondrial solute carrier family 25 in PC and its mechanism behind affecting immune infiltration and tumor energy metabolism. J Transl Med. 2022;20(1):592.","journal-title":"J Transl Med"},{"issue":"9","key":"1538_CR14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/em.21745","volume":"53","author":"MJ Prindle","year":"2012","unstructured":"Prindle MJ, Loeb LA. DNA polymerase delta in DNA replication and genome maintenance. Environ Mol Mutagen. 2012;53(9):666\u201382.","journal-title":"Environ Mol Mutagen"},{"key":"1538_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.618586","volume":"9","author":"Y Hou","year":"2021","unstructured":"Hou Y, et al. CTCF mediates replicative senescence through POLD1. Front Cell Dev Biol. 2021;9: 618586.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"1538_CR16","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1074\/jbc.272.8.4869","volume":"272","author":"L Zhao","year":"1997","unstructured":"Zhao L, Chang LS. The human POLD1 gene. Identification of an upstream activator sequence, activation by Sp1 and Sp3, and cell cycle regulation. J Biol Chem. 1997;272(8):4869\u201382.","journal-title":"J Biol Chem"},{"issue":"6","key":"1538_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11427-009-0077-5","volume":"52","author":"N Song","year":"2009","unstructured":"Song N, et al. Identification and functional analysis of a CDE\/CHR element in the POLD1 promoter. Sci China C Life Sci. 2009;52(6):551\u20139.","journal-title":"Sci China C Life Sci"},{"issue":"32","key":"1538_CR18","doi-asserted-by":"publisher","first-page":"29729","DOI":"10.1074\/jbc.M101167200","volume":"276","author":"B Li","year":"2001","unstructured":"Li B, Lee MY. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem. 2001;276(32):29729\u201339.","journal-title":"J Biol Chem"},{"issue":"14","key":"1538_CR19","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00018-019-03070-z","volume":"76","author":"S Gao","year":"2019","unstructured":"Gao S, et al. E2F1 mediates the downregulation of POLD1 in replicative senescence. Cell Mol Life Sci. 2019;76(14):2833\u201350.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1538_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"FJ Groelly","year":"2023","unstructured":"Groelly FJ, et al. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23(2):78\u201394.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1538_CR21","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3390\/cancers15061905","volume":"15","author":"M Gola","year":"2023","unstructured":"Gola M, et al. Prospects of POLD1 in human cancers: a review. Cancers (Basel). 2023;15(6):1905.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1538_CR22","doi-asserted-by":"publisher","first-page":"19602","DOI":"10.1038\/s41598-023-46651-6","volume":"13","author":"M Oshima","year":"2023","unstructured":"Oshima M, et al. Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer. Sci Rep. 2023;13(1):19602.","journal-title":"Sci Rep"},{"issue":"9","key":"1538_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/dna.2023.0089","volume":"42","author":"Y Quan","year":"2023","unstructured":"Quan Y, et al. RNA-sequencing analysis indicates that N-cadherin promotes prostate cancer progression by the epigenetic modification of key genes. DNA Cell Biol. 2023;42(9):563\u201377.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"1538_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41467-017-00694-2","volume":"8","author":"Y Shen","year":"2017","unstructured":"Shen Y, et al. The catalytic subunit of DNA polymerase delta inhibits gammaTuRC activity and regulates Golgi-derived microtubules. Nat Commun. 2017;8(1):554.","journal-title":"Nat Commun"},{"issue":"2","key":"1538_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yexcr.2019.01.003","volume":"375","author":"Y Shen","year":"2019","unstructured":"Shen Y, Wang K, Qi RZ. The catalytic subunit of DNA polymerase delta is a nucleocytoplasmic shuttling protein. Exp Cell Res. 2019;375(2):36\u201340.","journal-title":"Exp Cell Res"},{"issue":"1","key":"1538_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12935-021-02131-3","volume":"21","author":"Y Pang","year":"2021","unstructured":"Pang Y, et al. Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Cancer Cell Int. 2021;21(1):463.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"1538_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207693","volume":"10","author":"H Kim","year":"2023","unstructured":"Kim H, et al. Transferrin receptor-mediated iron uptake promotes colon tumorigenesis. Adv Sci (Weinh). 2023;10(10): e2207693.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"1538_CR28","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.18632\/aging.204010","volume":"14","author":"CH Li","year":"2022","unstructured":"Li CH, Chan MH, Chang YC. The role of fructose 1,6-bisphosphate-mediated glycolysis\/gluconeogenesis genes in cancer prognosis. Aging (Albany NY). 2022;14(7):3233\u201358.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"1538_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3451","volume":"24","author":"CH Li","year":"2022","unstructured":"Li CH, et al. The CHST11 gene is linked to lung cancer and pulmonary fibrosis. J Gene Med. 2022;24(12): e3451.","journal-title":"J Gene Med"},{"issue":"3","key":"1538_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/cjp2.313","volume":"9","author":"CH Li","year":"2023","unstructured":"Li CH, et al. The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers. J Pathol Clin Res. 2023;9(3):165\u201381.","journal-title":"J Pathol Clin Res"},{"issue":"5","key":"1538_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/jcmm.17690","volume":"27","author":"CH Li","year":"2023","unstructured":"Li CH, et al. The cytoplasmic expression of FSTL3 correlates with colorectal cancer progression, metastasis status and prognosis. J Cell Mol Med. 2023;27(5):672\u201386.","journal-title":"J Cell Mol Med"},{"issue":"18","key":"1538_CR32","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.21037\/atm-21-4606","volume":"9","author":"J Cai","year":"2021","unstructured":"Cai J, et al. Identification of potential biomarkers in ovarian carcinoma and an evaluation of their prognostic value. Ann Transl Med. 2021;9(18):1472.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1538_CR33","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12(1):7311.","journal-title":"Nat Commun"},{"key":"1538_CR34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.aquatox.2018.10.015","volume":"205","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. Copper inhibits hatching of fish embryos via inducing reactive oxygen species and down-regulating Wnt signaling. Aquat Toxicol. 2018;205:156\u201364.","journal-title":"Aquat Toxicol"},{"issue":"1","key":"1538_CR35","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1038\/s41467-024-50073-x","volume":"15","author":"M Xian","year":"2024","unstructured":"Xian M, et al. Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 2024;15(1):5767.","journal-title":"Nat Commun"},{"key":"1538_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100062","volume":"62","author":"K Chemello","year":"2021","unstructured":"Chemello K, et al. Lipoprotein metabolism in familial hypercholesterolemia. J Lipid Res. 2021;62: 100062.","journal-title":"J Lipid Res"},{"issue":"9","key":"1538_CR37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/v13091754","volume":"13","author":"SG Sanmukh","year":"2021","unstructured":"Sanmukh SG, et al. Bacteriophages M13 and T4 increase the expression of anchorage-dependent survival pathway genes and down regulate androgen receptor expression in LNCaP prostate cell line. Viruses. 2021;13(9):1754.","journal-title":"Viruses"},{"issue":"10","key":"1538_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/stmcls\/sxae047","volume":"42","author":"L Chen","year":"2024","unstructured":"Chen L, et al. Integrin-linked kinase control dental pulp stem cell senescence via the mTOR signaling pathway. Stem Cells. 2024;42(10):861\u201373.","journal-title":"Stem Cells"},{"issue":"4","key":"1538_CR39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/15548627.2020.1739445","volume":"17","author":"B Xie","year":"2021","unstructured":"Xie B, et al. Induction of autophagy and suppression of type I IFN secretion by CSFV. Autophagy. 2021;17(4):925\u201347.","journal-title":"Autophagy"},{"issue":"2","key":"1538_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4161\/auto.26863","volume":"10","author":"LM Harder","year":"2014","unstructured":"Harder LM, Bunkenborg J, Andersen JS. Inducing autophagy: a comparative phosphoproteomic study of the cellular response to ammonia and rapamycin. Autophagy. 2014;10(2):339\u201355.","journal-title":"Autophagy"},{"issue":"7","key":"1538_CR41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/15548627.2015.1049800","volume":"11","author":"Q Luan","year":"2015","unstructured":"Luan Q, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 2015;11(7):975\u201394.","journal-title":"Autophagy"},{"key":"1538_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/10286020.2024.2371050","volume":"27","author":"XH Yuan","year":"2024","unstructured":"Yuan XH, et al. Fuzheng Huayu recipe inhibits bleomycin-induced pulmonary fibrosis in rats by inhibiting M2 polarization of macrophages via the oxidative phosphorylation pathway. J Asian Nat Prod Res. 2024;27:62.","journal-title":"J Asian Nat Prod Res"},{"issue":"3","key":"1538_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ymgme.2020.10.005","volume":"131","author":"F Tort","year":"2020","unstructured":"Tort F, et al. Biallelic mutations in NDUFA8 cause complex I deficiency in two siblings with favorable clinical evolution. Mol Genet Metab. 2020;131(3):349\u201357.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"1538_CR44","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.bbabio.2011.09.013","volume":"1807","author":"CE Dieteren","year":"2011","unstructured":"Dieteren CE, et al. Defective mitochondrial translation differently affects the live cell dynamics of complex I subunits. Biochim Biophys Acta. 2011;1807(12):1624\u201333.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"1538_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/1440-1681.13821","volume":"50","author":"Q Pan","year":"2023","unstructured":"Pan Q, Xie X, Yuan Q. Monocarboxylate transporter 4 protects against myocardial ischemia\/reperfusion injury by inducing oxidative phosphorylation\/glycolysis interconversion and inhibiting oxidative stress. Clin Exp Pharmacol Physiol. 2023;50(12):954\u201363.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1538_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/RAF-21-0064","volume":"3","author":"LA Bartho","year":"2022","unstructured":"Bartho LA, et al. The effect of gestational age on mitochondrial properties of the mouse placenta. Reprod Fertil. 2022;3(1):19\u201329.","journal-title":"Reprod Fertil"},{"issue":"2","key":"1538_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/15548627.2015.1017182","volume":"11","author":"B Rah","year":"2015","unstructured":"Rah B, et al. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells. Autophagy. 2015;11(2):314\u201331.","journal-title":"Autophagy"},{"issue":"1","key":"1538_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/cam4.4440","volume":"11","author":"G Luo","year":"2022","unstructured":"Luo G, et al. Dcf1 induces glioblastoma cells apoptosis by blocking autophagy. Cancer Med. 2022;11(1):207\u201323.","journal-title":"Cancer Med"},{"key":"1538_CR49","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15629","volume":"11","author":"R Yang","year":"2023","unstructured":"Yang R, et al. Effect of prolactin on cytotoxicity and oxidative stress in ovine ovarian granulosa cells. PeerJ. 2023;11: e15629.","journal-title":"PeerJ"},{"issue":"1","key":"1538_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jpha.2023.08.006","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, et al. Hydralazine represses Fpn ubiquitination to rescue injured neurons via competitive binding to UBA52. J Pharm Anal. 2024;14(1):86\u201399.","journal-title":"J Pharm Anal"},{"issue":"11","key":"1538_CR51","first-page":"7166","volume":"11","author":"F Wang","year":"2019","unstructured":"Wang F, et al. Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells. Am J Transl Res. 2019;11(11):7166\u201385.","journal-title":"Am J Transl Res"},{"key":"1538_CR52","doi-asserted-by":"publisher","first-page":"36780","DOI":"10.1038\/srep36780","volume":"6","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi M, et al. The ubiquitin hybrid gene UBA52 regulates ubiquitination of ribosome and sustains embryonic development. Sci Rep. 2016;6:36780.","journal-title":"Sci Rep"},{"issue":"13","key":"1538_CR53","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1080\/07391102.2021.1874532","volume":"40","author":"R Tiwari","year":"2022","unstructured":"Tiwari R, et al. Structural similarity-based prediction of host factors associated with SARS-CoV-2 infection and pathogenesis. J Biomol Struct Dyn. 2022;40(13):5868\u201379.","journal-title":"J Biomol Struct Dyn"},{"key":"1538_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106573","volume":"199","author":"L Chang","year":"2024","unstructured":"Chang L, et al. Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis. Neurobiol Dis. 2024;199: 106573.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1538_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221751","volume":"14","author":"RA Helmer","year":"2019","unstructured":"Helmer RA, et al. Helicase-like transcription factor (Hltf) gene-deletion promotes oxidative phosphorylation (OXPHOS) in colorectal tumors of AOM\/DSS-treated mice. PLoS ONE. 2019;14(8): e0221751.","journal-title":"PLoS ONE"},{"issue":"22","key":"1538_CR56","doi-asserted-by":"publisher","first-page":"e182087","DOI":"10.1172\/jci.insight.182087","volume":"9","author":"JS Carty","year":"2024","unstructured":"Carty JS, et al. Disruption of mitochondrial electron transport impairs urinary concentration via AMPK-dependent suppression of aquaporin 2. JCI Insight. 2024;9(22):e182087.","journal-title":"JCI Insight"},{"key":"1538_CR57","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.2147\/OTT.S249752","volume":"13","author":"D Liao","year":"2020","unstructured":"Liao D, et al. Identification of pannexin 2 as a novel marker correlating with ferroptosis and malignant phenotypes of prostate cancer cells. Onco Targets Ther. 2020;13:4411\u201321.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"1538_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152851","volume":"216","author":"G Yang","year":"2020","unstructured":"Yang G, et al. Long noncoding RNA TUG1 regulates prostate cancer cell proliferation, invasion and migration via the Nrf2 signaling axis. Pathol Res Pract. 2020;216(4): 152851.","journal-title":"Pathol Res Pract"},{"issue":"20","key":"1538_CR59","doi-asserted-by":"publisher","first-page":"15231","DOI":"10.3390\/ijms242015231","volume":"24","author":"C Currie","year":"2023","unstructured":"Currie C, et al. Assessing the potential of small peptides for altering expression levels of the iron-regulatory genes FTH1 and TFRC and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models. Int J Mol Sci. 2023;24(20):15231.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1538_CR60","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1158\/0008-5472.CAN-08-0121","volume":"68","author":"Y Ma","year":"2008","unstructured":"Ma Y, et al. A small-molecule E2F inhibitor blocks growth in a melanoma culture model. Cancer Res. 2008;68(15):6292\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"1538_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096357","volume":"9","author":"CA Kurtyka","year":"2014","unstructured":"Kurtyka CA, Chen L, Cress WD. E2F inhibition synergizes with paclitaxel in lung cancer cell lines. PLoS ONE. 2014;9(5): e96357.","journal-title":"PLoS ONE"},{"key":"1538_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/OTT.S125789","volume":"10","author":"T Huang","year":"2017","unstructured":"Huang T, et al. Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel. Onco Targets Ther. 2017;10:439\u201346.","journal-title":"Onco Targets Ther"},{"issue":"48","key":"1538_CR63","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1038\/onc.2011.654","volume":"31","author":"M Sangwan","year":"2012","unstructured":"Sangwan M, et al. Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation. Oncogene. 2012;31(48):5019\u201328.","journal-title":"Oncogene"},{"issue":"6","key":"1538_CR64","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jid.2019.09.025","volume":"140","author":"X Liu","year":"2020","unstructured":"Liu X, et al. E2F1\/IGF-1R loop contributes to BRAF inhibitor resistance in melanoma. J Invest Dermatol. 2020;140(6):1295-1299 e1.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1538_CR65","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bmcl.2018.12.037","volume":"29","author":"M Rosales-Hurtado","year":"2019","unstructured":"Rosales-Hurtado M, et al. Improved synthesis, resolution, absolute configuration determination and biological evaluation of HLM006474 enantiomers. Bioorg Med Chem Lett. 2019;29(3):380\u20132.","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"1538_CR66","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/HYPERTENSIONAHA.123.21241","volume":"80","author":"D Yi","year":"2023","unstructured":"Yi D, et al. E2F1 mediates SOX17 deficiency-induced pulmonary hypertension. Hypertension. 2023;80(11):2357\u201371.","journal-title":"Hypertension"},{"issue":"7","key":"1538_CR67","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.3390\/ijms24076849","volume":"24","author":"J Tian","year":"2023","unstructured":"Tian J, et al. POLD1 as a prognostic biomarker correlated with cell proliferation and immune infiltration in clear cell renal cell carcinoma. Int J Mol Sci. 2023;24(7):6849.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1538_CR68","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ncpuro1296","volume":"6","author":"WP Harris","year":"2009","unstructured":"Harris WP, et al. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol. 2009;6(2):76\u201385.","journal-title":"Nat Clin Pract Urol"},{"key":"1538_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217090","volume":"598","author":"YN Liu","year":"2024","unstructured":"Liu YN, et al. Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer. Cancer Lett. 2024;598: 217090.","journal-title":"Cancer Lett"},{"issue":"7","key":"1538_CR70","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1177\/1066896921997132","volume":"29","author":"J Munkhdelger","year":"2021","unstructured":"Munkhdelger J, et al. Basaloid squamous cell carcinoma of the uterine cervix: report of a case with molecular analysis. Int J Surg Pathol. 2021;29(7):770\u20134.","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"1538_CR71","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","volume":"40","author":"N Formaggio","year":"2021","unstructured":"Formaggio N, Rubin MA, Theurillat JP. Loss and revival of androgen receptor signaling in advanced prostate cancer. Oncogene. 2021;40(7):1205\u201316.","journal-title":"Oncogene"},{"issue":"12","key":"1538_CR72","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrurol.2014.243","volume":"11","author":"F Claessens","year":"2014","unstructured":"Claessens F, et al. Emerging mechanisms of enzalutamide resistance in prostate cancer. Nat Rev Urol. 2014;11(12):712\u20136.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"1538_CR73","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","volume":"17","author":"DA Bader","year":"2020","unstructured":"Bader DA, McGuire SE. Tumour metabolism and its unique properties in prostate adenocarcinoma. Nat Rev Urol. 2020;17(4):214\u201331.","journal-title":"Nat Rev Urol"},{"issue":"9","key":"1538_CR74","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1021\/acs.jproteome.0c00282","volume":"19","author":"H Zheng","year":"2020","unstructured":"Zheng H, et al. Distinct metabolic signatures of hormone-sensitive and castration-resistant prostate cancer revealed by a (1)H NMR-based metabolomics of biopsy tissue. J Proteome Res. 2020;19(9):3741\u20139.","journal-title":"J Proteome Res"},{"issue":"5","key":"1538_CR75","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00432-022-04371-w","volume":"149","author":"AK Beier","year":"2023","unstructured":"Beier AK, et al. Metabolic changes during prostate cancer development and progression. J Cancer Res Clin Oncol. 2023;149(5):2259\u201370.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"1538_CR76","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s11255-019-02261-8","volume":"51","author":"I Selvi","year":"2019","unstructured":"Selvi I, et al. The importance of plasma arginine level and its downstream metabolites in diagnosing prostate cancer. Int Urol Nephrol. 2019;51(11):1975\u201383.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1538_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12885-020-06908-z","volume":"20","author":"I Dudka","year":"2020","unstructured":"Dudka I, et al. Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status. BMC Cancer. 2020;20(1):437.","journal-title":"BMC Cancer"},{"issue":"7","key":"1538_CR78","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/pros.22793","volume":"74","author":"LN Thomas","year":"2014","unstructured":"Thomas LN, et al. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting. Prostate. 2014;74(7):732\u201342.","journal-title":"Prostate"},{"issue":"2","key":"1538_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055146","volume":"8","author":"Y Ino","year":"2013","unstructured":"Ino Y, et al. Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer. PLoS ONE. 2013;8(2): e55146.","journal-title":"PLoS ONE"},{"issue":"1","key":"1538_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, et al. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1538_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"4","key":"1538_CR82","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1538_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101708","volume":"35","author":"K Gao","year":"2023","unstructured":"Gao K, et al. DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest. Transl Oncol. 2023;35: 101708.","journal-title":"Transl Oncol"},{"issue":"19","key":"1538_CR84","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.3390\/cancers14194952","volume":"14","author":"M Hamidi","year":"2022","unstructured":"Hamidi M, et al. Targeting E2F sensitizes prostate cancer cells to drug-induced replication stress by promoting unscheduled CDK1 activity. Cancers (Basel). 2022;14(19):4952.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1538_CR85","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1124\/mol.113.090688","volume":"85","author":"M Wu","year":"2014","unstructured":"Wu M, et al. Dynamic regulation of Rad51 by E2F1 and p53 in prostate cancer cells upon drug-induced DNA damage under hypoxia. Mol Pharmacol. 2014;85(6):866\u201376.","journal-title":"Mol Pharmacol"},{"issue":"20","key":"1538_CR86","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010734","volume":"97","author":"S Li","year":"2018","unstructured":"Li S, et al. Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia. Medicine (Baltimore). 2018;97(20): e10734.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1538_CR87","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.21037\/tcr-21-1532","volume":"10","author":"D Wang","year":"2021","unstructured":"Wang D, et al. Comprehensive analysis of the functional and prognostic value of E2F transcription factors in human prostate cancer through data mining and experimental validation. Transl Cancer Res. 2021;10(12):5095\u2013109.","journal-title":"Transl Cancer Res"},{"issue":"3","key":"1538_CR88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.01.018","volume":"35","author":"M Reina-Campos","year":"2019","unstructured":"Reina-Campos M, et al. Increased serine and one-carbon pathway metabolism by PKClambda\/iota deficiency promotes neuroendocrine prostate cancer. Cancer Cell. 2019;35(3):385-400 e9.","journal-title":"Cancer Cell"},{"issue":"1","key":"1538_CR89","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1186\/s12885-023-11707-3","volume":"23","author":"X Dai","year":"2023","unstructured":"Dai X, et al. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells. BMC Cancer. 2023;23(1):1241.","journal-title":"BMC Cancer"},{"issue":"1","key":"1538_CR90","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/21655979.2021.2016086","volume":"13","author":"X Hong","year":"2022","unstructured":"Hong X, et al. Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes. Bioengineered. 2022;13(1):995\u20131012.","journal-title":"Bioengineered"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01538-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T14:01:41Z","timestamp":1750514501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01538-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1538"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01538-4","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}